Approach [spco]    
Non-alcoholic Fatty Liver Disease [dsyn]    
patient [podg]    
Diabetes [dsyn]    
Prevalence [qnco]    
Diabetes Type 2 [dsyn]    
Expectancy [idcn]    
To [qlco]    
Increase [ftcn]    
In [qnco]    
Parallel [qlco]    
Obese [dsyn]    
Rate [acty]    
Age [orgf]    
Population [qnco]    
Recent [tmco]    
studies [lbpr]    
Show [inpr]    
Diabetes Type 2 [dsyn]    
Associated [qlco]    
Increase [ftcn]    
Risk [qlco]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Leading [tmco]    
cause [ftcn]    
Chronic liver disease [dsyn]    
Individual [popg]    
Nonalcoholic steatohepatitis [dsyn]    
More [ftcn]    
Advance [qlco]    
Stage [tmco]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Fibrosis [patf]    
Cirrhosis [dsyn]    
End Stage Liver Disease [dsyn]    
Hepatocellular carcinoma [neop]    
Individual [popg]    
Diabetes Type 2 [dsyn]    
Likely [qlco]    
hepatic complications [patf]    
Present [qnco]    
Clinical [qlco]    
Review [inpr]    
Potential [qlco]    
IMPACT [gngm]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Diagnosis [fndg]    
Diabetes Type 2 [dsyn]    
Risk factor [qnco]    
Nonalcoholic steatohepatitis [dsyn]    
Nonalcoholic steatohepatitis [dsyn]    
Fibrosis [patf]    
limit [ftcn]    
Currently [tmco]    
used [fndg]    
Tool [mnob]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Diagnosis [fndg]    
Stage [ftcn]    
Provide [acty]    
Insight [menp]    
Future [tmco]    
development [phsf]    
In the Field [spco]    
Present [qnco]    
Example [cnce]    
Non-alcoholic Fatty Liver Disease [dsyn]    
screen [hlca]    
Protocol [inpr]    
Therapeutic [topp]    
Option [ftcn]    
Currently [tmco]    
Available [ftcn]    
patient [podg]    
